These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Pedraza N, Solanes G, Carmona MC, Iglesias R, Viñas O, Mampel T, Vazquez M, Giralt M, Villarroya F. Diabetes; 2000 Jul; 49(7):1224-30. PubMed ID: 10909982 [Abstract] [Full Text] [Related]
28. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma. Iwata M, Haruta T, Usui I, Takata Y, Takano A, Uno T, Kawahara J, Ueno E, Sasaoka T, Ishibashi O, Kobayashi M. Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412 [Abstract] [Full Text] [Related]
32. Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Sell H, Berger JP, Samson P, Castriota G, Lalonde J, Deshaies Y, Richard D. Endocrinology; 2004 Aug 13; 145(8):3925-34. PubMed ID: 15131020 [Abstract] [Full Text] [Related]
33. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. Vidal-Puig A, Jimenez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE. J Clin Invest; 1996 Jun 01; 97(11):2553-61. PubMed ID: 8647948 [Abstract] [Full Text] [Related]
34. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML. J Biol Chem; 2003 Sep 05; 278(36):34268-76. PubMed ID: 12805374 [Abstract] [Full Text] [Related]
35. Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. Bedoucha M, Atzpodien E, Boelsterli UA. J Hepatol; 2001 Jul 05; 35(1):17-23. PubMed ID: 11495036 [Abstract] [Full Text] [Related]
36. [Mechanisms of action of thiazolidinediones]. Girard J. Diabetes Metab; 2001 Apr 05; 27(2 Pt 2):271-8. PubMed ID: 11452221 [Abstract] [Full Text] [Related]
37. Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes. Cabrero A, Alegret M, Sánchez RM, Adzet T, Laguna JC, Vázquez M. FEBS Lett; 2000 Oct 27; 484(1):37-42. PubMed ID: 11056218 [Abstract] [Full Text] [Related]
38. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. Guan Y, Zhang Y, Schneider A, Davis L, Breyer RM, Breyer MD. Am J Physiol Renal Physiol; 2001 Dec 27; 281(6):F1036-46. PubMed ID: 11704554 [Abstract] [Full Text] [Related]